1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design

.

Source: Expert Opinion on Drug Discovery - April 28, 2021 Category: Drugs & Pharmacology Authors: Faheem Banoth Karan Kumar Kondapalli Venkata Gowri Chandra Sekhar Subhash Chander Selvaraj Kunjiappan Sankaranarayanan Murugesan Source Type: research